The Ahmed ClearPath glaucoma drainage device has been commercially launched in the United States. Available in 350 mm2 and 250 mm2 sizes, the implant includes a flexible plate with a contour that conforms to the curvature of the eye and suture fixation points positioned more anteriorly on the device in comparison to other valveless drainage devices. It is designed to address tube shunt surgery challenges and comes with an optional pre-threaded ripcord and a 23-gauge needle. One feature of the Ahmed ClearPath implant is a flexible plate with a contour that closely conforms to the curvature of the eye. In addition, the suture fixation points are positioned more anteriorly on the device compared to other valveless drainage devices. By making the suture points more visible and accessible, the company said the surgeon may find securing this implant to the eye more convenient. The device or procedures are reserved for mild to moderate glaucoma cases.
With the successful execution of the first-in-human telerobotic intervention, we are now opening new avenues and this is going to change the global scenario of telerobotic interventions. Dr. Tejas M. Patel, Chairman and Chief Interventional Cardiologist, Apex Heart Institute, Ahmedabad
Max Healthcare recently launched a daycare cancer centre right in the heart of Gurugram. The centre marks Max Healthcare’s expansion into standalone oncology care.
Distinguishing several medical devices from drugs and cosmetics in the most recent policies is giving better impetus to fulfil healthcare needs from manufacturing perspective like prioritising essential unmet needs.
At the recently concluded MEDLAB expo, the ERBA Group, launched their latest hematology analyzers, H 360 and H 560. Designed for improving lab efficiency,...
Touted as India’s first women hospital, Gaudium Women Hospital was inaugurated on March 8, International Women’s Day, at Janakpuri in New Delhi by Bollywood...